This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Kasei Corporation. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Shuitiro Kadowaki: Innovator in Heterocyclic Compounds
Introduction
Shuitiro Kadowaki is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of chemistry, particularly in the development of novel heterocyclic compounds. His work has implications for medical science, especially in the treatment of inflammatory conditions.
Latest Patents
Kadowaki holds a patent for a heterocyclic compound that is represented by a specific chemical formula. This compound has been shown to inhibit lipoxygenase, which plays a crucial role in the formation of leukotrienes. As a result, it is useful for the prevention and treatment of inflammation, rheumatism, and various allergic diseases. He has 1 patent to his name.
Career Highlights
Shuitiro Kadowaki is associated with Mitsubishi Kasei Corporation, where he has been able to apply his expertise in chemistry to develop innovative solutions. His work has been recognized within the industry for its potential impact on health and medicine.
Collaborations
Kadowaki has collaborated with notable coworkers such as Masaru Ubasawa and Yoshio Hayashi. Their combined efforts have contributed to advancements in the field of heterocyclic compounds.
Conclusion
Shuitiro Kadowaki's contributions to the field of chemistry, particularly through his patented heterocyclic compound, highlight his role as an innovator. His work continues to have a significant impact on medical science and the treatment of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile